UY33876A - Derivados de 5-alquinil-piridinas con efecto inhibitorio sobre la actividad de pi3k-alfa - Google Patents

Derivados de 5-alquinil-piridinas con efecto inhibitorio sobre la actividad de pi3k-alfa

Info

Publication number
UY33876A
UY33876A UY0001033876A UY33876A UY33876A UY 33876 A UY33876 A UY 33876A UY 0001033876 A UY0001033876 A UY 0001033876A UY 33876 A UY33876 A UY 33876A UY 33876 A UY33876 A UY 33876A
Authority
UY
Uruguay
Prior art keywords
activity
piridinas
alquinil
pi3k
alfa
Prior art date
Application number
UY0001033876A
Other languages
English (en)
Spanish (es)
Inventor
Kraemer Oliver
Lars Van Der Veen
Wunberg Tobias
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of UY33876A publication Critical patent/UY33876A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
UY0001033876A 2011-01-26 2012-01-25 Derivados de 5-alquinil-piridinas con efecto inhibitorio sobre la actividad de pi3k-alfa UY33876A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11152222 2011-01-26

Publications (1)

Publication Number Publication Date
UY33876A true UY33876A (es) 2012-07-31

Family

ID=43736078

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001033876A UY33876A (es) 2011-01-26 2012-01-25 Derivados de 5-alquinil-piridinas con efecto inhibitorio sobre la actividad de pi3k-alfa

Country Status (5)

Country Link
US (1) US8466162B2 (enExample)
EP (1) EP2668178B1 (enExample)
JP (1) JP2014503570A (enExample)
UY (1) UY33876A (enExample)
WO (1) WO2012101184A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10247481B2 (en) 2013-01-28 2019-04-02 Carrier Corporation Multiple tube bank heat exchange unit with manifold assembly
US10337799B2 (en) 2013-11-25 2019-07-02 Carrier Corporation Dual duty microchannel heat exchanger
GR1009604B (el) * 2018-08-24 2019-09-20 Ιδρυμα Ιατροβιολογικων Ερευνων Της Ακαδημιας Αθηνων Μεθοδος προετοιμασιας και χρηση αναστολεων της 3-φωσφοινοσιδιτικης κινασης για καρκινικες νοσους
CN118530185B (zh) * 2024-07-25 2024-10-22 山东仁一生物科技有限责任公司 一种制备4-羟基-6-甲基嘧啶的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7459562B2 (en) * 2004-04-23 2008-12-02 Bristol-Myers Squibb Company Monocyclic heterocycles as kinase inhibitors
AU2005293607A1 (en) 2004-10-07 2006-04-20 Boehringer Ingelheim International Gmbh PI3 kinases
US7776869B2 (en) * 2004-10-18 2010-08-17 Amgen Inc. Heteroaryl-substituted alkyne compounds and method of use
US20080146599A1 (en) * 2005-02-01 2008-06-19 Astrazeneca Ab Pyrimidine Compounds Having Tie-2 (Tek) Inhibitory Activity
US20080194552A1 (en) 2005-03-31 2008-08-14 Astrazeneca Ab Aminopyrimidine Derivatives With Tie2 Inhibiting Activity
PE20091617A1 (es) 2008-03-13 2009-11-12 Boehringer Ingelheim Int Tiazolil-dihidro-indazoles
MX2011000729A (es) * 2008-07-29 2011-03-15 Boehringer Ingelheim Int 5-alquinil-pirimidinas.
AR076332A1 (es) * 2009-04-21 2011-06-01 Boehringer Ingelheim Int Derivados heterociclicos de 5-alquinil-piridinas, composiciones farmaceuticas que los comprenden y uso de los mismos para el tratamiento y/o prevencion del cancer, procesos inflamatorios, autoinmunes, y/o infecciones.
UY33198A (es) * 2010-01-26 2011-08-31 Boehringer Ingelheim Int 5-alquinil-pirimidinas.
US8633183B2 (en) * 2010-01-26 2014-01-21 Boehringer Ingelheim International Gmbh 5-alkynyl-pyrimidines
TW201245176A (en) * 2011-01-26 2012-11-16 Boehringer Ingelheim Int New 5-alkynyl-pyridines

Also Published As

Publication number Publication date
US8466162B2 (en) 2013-06-18
EP2668178B1 (en) 2016-01-20
WO2012101184A1 (en) 2012-08-02
US20130023533A1 (en) 2013-01-24
JP2014503570A (ja) 2014-02-13
EP2668178A1 (en) 2013-12-04

Similar Documents

Publication Publication Date Title
CO2020007218A2 (es) Nuevas piridopirimidinonas sustituidas con bencilamino y derivados como inhibidores de sos1
PE20151023A1 (es) Triazolopirazinas
ECSP14018375A (es) 6-alquinilo piridinas como miméticos smac
DOP2015000241A (es) Compuestos de biaril-amida como inhibidores de cinasa
CL2014002873A1 (es) Compuestos derivados de pirimidin-amina o triazin-amina, inhibidores de adn-pk; composicion farmaceutica; y su uso para el tratamiento del cancer.
NI201300018A (es) Promotores de apoptosis de n - acilsulfonamidas
UY33890A (es) Nuevas azaindolilfenil sulfonamidas como inhibidores de serina/ treonina cinasa
CR20150485A (es) Compuestos triciclicos como inhibidores de la inmunosupresion mediada por el metabolismo del triptofano
MX2019003468A (es) Derivados de tieno [3,2-d]pirimidina que tienen actividad inhibidora de las cinasas de proteina.
MX386935B (es) Profármacos de fumaratos y su uso en el tratamiento de diferentes enfermedades.
DOP2015000157A (es) Lactamas fusionadas de arilo y heteroarilo
ECSP13012499A (es) Nuevos compuestos
CR20150217A (es) Inhibidores de histona demetilasas
DOP2013000192A (es) Compuestos y composiciones como inhibidores de la trk
DOP2012000257A (es) Derivados del acido 1-amino-2-ciclopropiletilboronico
CL2015001916A1 (es) Derivados de pirimidona y su uso en el tratamiento, mejora o prevención de una enfermedad viral.
DOP2010000013A (es) Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas
ECSP13013068A (es) Halogenoalquil-1,3-oxazinas como inhibidores de la bace1 y/o bace2
GT201400085A (es) Profármaco de adrenomedulina basado en polietilenglicol y su uso
CO6491060A2 (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
CR20140144A (es) Derivados de estra-1,3,5 (10), 16-tetraen-3-carboxamida, procedimientos para su preparación, preparados farmacéuticos que los contienen, así como su uso para la preparación de medicamentos
UY35711A (es) Bis-amidopiridinas como moduladores de la actividad de iap y sus usos como miméticos de smac
UY35710A (es) 6-alquinilpiridinas como moduladores de la actividad de iap y sus usos como miméticos de smac
CL2015000039A1 (es) Derivados estra-1,3,5(10),16-tetraeno-3-sustituidos, preparaciones farmacéuticas que los comprenden y su uso en la preparación de medicamentos para tratar la endometriosis.
PE20170193A1 (es) Derivados de 6-alquinil-piridina